Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
4.030
+0.190 (4.95%)
At close: Dec 5, 2025, 4:00 PM EST
3.910
-0.120 (-2.98%)
After-hours: Dec 5, 2025, 7:16 PM EST
Sintx Technologies Employees
Sintx Technologies had 20 employees as of December 31, 2024. The number of employees decreased by 23 or -53.49% compared to the previous year.
Employees
20
Change (1Y)
-23
Growth (1Y)
-53.49%
Revenue / Employee
$63,500
Profits / Employee
-$828,150
Market Cap
15.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SINT News
- 4 days ago - SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants - GlobeNewsWire
- 4 weeks ago - SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System - GlobeNewsWire
- 6 weeks ago - SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System - GlobeNewsWire
- 7 weeks ago - SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics - GlobeNewsWire
- 3 months ago - SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds - GlobeNewsWire
- 3 months ago - SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent - GlobeNewsWire
- 4 months ago - SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition - GlobeNewsWire
- 4 months ago - SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates - GlobeNewsWire